Back to search results

Biomarker Development for Muscular Dystrophies

Abroad (travel likely)Recruiting

Conditions

Myotonic Dystrophy · Duchenne Muscular Dystrophy · Becker Muscular Dystrophy · Facioscapulohumeral Muscular Dystrophy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Boston Children's Hospital, Boston, Massachusetts, United States

  • Brigham and Women's Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (Louis Beers) · lbeers@bwh.harvard.edu
    Contact: Principal Investigator (Anthony Amato, MD)

  • Massachusetts General Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (Tamkin Shahraki, MD) · tshahraki@mgh.harvard.edu · 617-726-7506
    Contact: Principal Investigator (Thurman M. Wheeler, MD)
    Paloma Gonzalez-Perez, MD, PhD (Sub-investigator)

  • Wake Forest University, Winston-Salem, North Carolina, United States

    Contact: Study coordinator (Constance Linville) · clinvill@wakehealth.edu · 336-716-4568
    Contact: Principal Investigator (Araya Puwanant, MD)

  • University of Pittsburgh, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Kerry M. Oddis, RN, CCRC) · kmoddis@upmc.edu · 412-692-4918
    Contact: Principal Investigator (Paula R. Clemens, MD)
Study leads

  • Thurman M. Wheeler, MD

    Principal Investigator

    Massachusetts General Hospital

View source on ClinicalTrials.gov(opens in a new tab)